Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.186
Neutral
RSI(14)
54.078
Neutral
STOCH(KDJ)(9,3,3)
19.687
Sell
ATR(14)
0.378
High Vlolatility
CCI(14)
-107.655
Sell
Williams %R
78.378
Sell
TRIX(12,20)
0.832
Sell
StochRSI(14)
0.000
Oversold
Search
Maravai LifeSciences Holdings Inc
MRVIAdd to Watchlist
6.570USD
-0.180-2.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.70BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.67%
5 Days
-2.81%
1 Month
+8.77%
6 Months
+94.96%
Year to Date
+102.15%
1 Year
+195.95%
Key Figures
6.760Open
6.770High
1.09MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.75%Turnover Ratio
6.750Prev. Close
6.450Low
5.06MTurnover
LossP/E Static
4.50P/B
0.00%Div Yield TTM
-22.03%ROA
4.99552wk High
0.61Volume Ratio
-144.85MNet Profit
145.32MShares
-0.7226EPS TTM
0.69Beta
-40.83%ROE
1.99052wk Low
4.74%Amplitude
51.19%Gross Margin
1.70BMarket Cap
3.84Reward/Risk
3.75%Risk Rate
TradingKey Stock Score of Maravai LifeSciences Holdings Inc
Currency: USD Updated: 2026-07-31Key Insights
Maravai LifeSciences Holdings Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 31 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.90.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Maravai LifeSciences Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Maravai LifeSciences Holdings Inc Highlights
StrengthsRisks
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.
Undervalued
The company’s latest PE is -9.09, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 140.69M shares, decreasing 17.15% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 1.17M shares of this stock.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
5.900
Target Price
-10.20%
Upside Space
Maravai LifeSciences Holdings Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
9
analysts
Buy
Current Rating
5.900
Target Price
-10.20%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Maravai LifeSciences Holdings Inc
MRVI
9
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
6.692
Sell
MA10
6.846
Sell
MA20
6.617
Sell
MA50
5.752
Buy
MA100
4.619
Buy
MA200
4.029
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Maravai LifeSciences Holdings Inc Info
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.
Ticker SymbolMRVI
CompanyMaravai LifeSciences Holdings Inc
CEOBrust (Bernd)
Websitehttps://www.maravai.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52739.700
+361.700 (+0.69%)
28500.400
+339.500 (+1.21%)
7529.100
+54.000 (+0.72%)
14607.000
-142.000 (-0.96%)
62958.000
+106.000 (+0.17%)
6395.500
+30.100 (+0.47%)
79.402
-6.532 (-7.60%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4048.970
+7.540 (+0.19%)
FAQs
What is the current price of Maravai LifeSciences Holdings Inc (MRVI)?
The current price of Maravai LifeSciences Holdings Inc (MRVI) is 6.57.
What is the symbol of Maravai LifeSciences Holdings Inc?
The ticker symbol of Maravai LifeSciences Holdings Inc is MRVI.
What is the 52-week high of Maravai LifeSciences Holdings Inc?
The 52-week high of Maravai LifeSciences Holdings Inc is 5.00.
What is the 52-week low of Maravai LifeSciences Holdings Inc?
The 52-week low of Maravai LifeSciences Holdings Inc is 1.99.
What is the market capitalization of Maravai LifeSciences Holdings Inc?
The market capitalization of Maravai LifeSciences Holdings Inc is 1.70B.
Is Maravai LifeSciences Holdings Inc (MRVI) currently rated as Buy, Hold, or Sell?
According to analysts, Maravai LifeSciences Holdings Inc (MRVI) has an overall rating of Buy, with a price target of 5.90.
What is the Earnings Per Share (EPS TTM) of Maravai LifeSciences Holdings Inc (MRVI)?
The Earnings Per Share (EPS TTM) of Maravai LifeSciences Holdings Inc (MRVI) is -0.91.